Lilly unveils $30m NCD partnership initiative in developing world
This article was originally published in Scrip
Executive Summary
Eli Lilly and Company expects to invest $30 million over five years as part of an initiative aimed at tackling non-communicable diseases (NCDs) in developing countries.